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Genome-wide association studies (GWAS) have identified thousands of genomic regions
affecting complex diseases. The next challenge is to elucidate the causal genes and
mechanisms involved. One approach is to use statistical colocalization to assess shared
genetic aetiology across multiple related traits (e.g. molecular traits, metabolic pathways and
complex diseases) to identify causal pathways, prioritize causal variants and evaluate
pleiotropy. We propose HyPrColoc (Hypothesis Prioritisation for multi-trait Colocalization),
an efficient deterministic Bayesian algorithm using GWAS summary statistics that can detect
colocalization across vast numbers of traits simultaneously (e.g. 100 traits can be jointly
analysed in around 1 s). We perform a genome-wide multi-trait colocalization analysis of
coronary heart disease (CHD) and fourteen related traits, identifying 43 regions in which
CHD colocalized with ≥1 trait, including 5 previously unknown CHD loci. Across the 43 loci,
we further integrate gene and protein expression quantitative trait loci to identify candidate
causal genes.
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Genome-wide association studies (GWAS) have identifiedthousands of genomic loci associated with complex traitsand diseases (https://www.ebi.ac.uk/gwas/). However,
identification of the causal mechanisms underlying these asso-
ciations and subsequent biological insights have not been as
forthcoming, due to issues such as linkage disequilibrium (LD)
and incomplete genomic coverage. One approach to aid biological
insight following GWAS is to make use of functional data. For
example, candidate causal genes can be proposed when the
overlap in association signals between a complex trait and func-
tional data (e.g. gene expression) is a consequence of both traits
sharing a causal variant, i.e. the association signals for both traits
colocalize. The abundance of significant associations identified
by GWAS means that chance overlap between association signals
for different traits is likely1. Consequently, overlap does not
by itself allow us to identify causal variants1,2. Statistical coloca-
lization methodologies seek to resolve this. By constructing a
formal statistical model, colocalization approaches have been
successful in identifying whether a molecular trait (e.g. gene
expression) and a disease trait share a causal variant in a genomic
region3–7, and potentially prioritise a candidate causal gene.
Recently it has been proposed that colocalization methodologies
can be further enhanced by integrating additional information
from multiple intermediate traits linked to disease, e.g. protein
expression, metabolite levels8. The underlying hypothesis of
multi-trait colocalization is that if a variant is associated with
multiple related traits then this provides stronger evidence
that the variant may be causal8. Thus, multi-trait colocalization
aims to increase power to identify causal variants. We show that
by using multi-level functional datasets in this way can reveal
candidate causal genes and pathways underpinning complex
disease.
A number of statistical methods have been developed to assess
whether association signals across a pair of traits colocalize3–7.
Some methods assess colocalization between a pair of traits using
individual participant data9,10, limiting their applicability. In
contrast, the COLOC algorithm uses GWAS summary statistics2.
This approach works by systematically exploring putative causal
configurations, where each configuration locates a causal variant
for one or both traits, under the assumption that there is at most
one causal variant per trait. COLOC was recently extended to the
multi-trait framework, MOLOC8. The authors achieved a 1.5-fold
increase in candidate causal gene identification when a third
relevant trait was included in colocalization analyses relative to
results from two traits. However, the approach is computationally
impractical beyond 4 traits due to prohibitive computational
complexity arising from the exponential growth in the number of
causal configurations that must be explored with each additional
trait analysed.
Here we present a computationally efficient method, hypoth-
esis prioritisation for multi-trait colocalization (HyPrColoc), to
identify colocalized association signals using summary statistics
on large numbers of traits. The approach extends the underlying
methodology of COLOC and MOLOC. Our major result is that
the posterior probability of colocalization at a single causal var-
iant can be accurately approximated by enumerating only a small
number of putative causal configurations. Moreover, HyPrColoc
identifies subsets (which we refer to as clusters) of traits which
colocalize at distinct causal variants in the genomic locus by
employing a novel branch and bound divisive clustering algo-
rithm. We show that the multi-trait clustering method of HyPrColoc
has several performance advantages over alternative colocalization
approaches and apply HyPrColoc genome-wide to coronary heart
disease (CHD) and many related traits11,12, identifying known and
previously unknown candidate CHD genetic risk loci with colocalized
associations across these traits.
Results
Overview. HyPrColoc is a Bayesian method for identifying shared
genetic associations between complex traits in a particular gene
region using summary GWAS results. HyPrColoc provides two
principal novelties: (i) Efficient computation of the posterior
probability that all m traits share a causal variant (which we refer
to as the posterior probability of full colocalization, PPFC); and
(ii) partitioning of traits into clusters, such that each cluster
comprises traits sharing a causal variant. HyPrColoc only requires
regression coefficients and their corresponding standard errors
from summary GWAS (for binary traits these can be on the log-
odds scale, see Methods). The approach makes three key
assumptions: (i) for non-independent studies, that the GWAS
results are from the same underlying population, i.e. that the LD
pattern is the same across studies, (ii) that there is at most one
causal variant in the genomic region for each trait (we assess
limitations of this assumption when there are multiple causal
variants below), and (iii) that these causal variants are either
directly typed or well imputed in all of the GWAS datasets2,8.
Description of the HyPrColoc method. We define a putative
causal configuration matrix S to be a binary m ×Q matrix, where
m is the number of traits and Q is the number of variants. To
increase the probability of identifying any underlying causal
variant(s) in the region, the number of SNPs Q included in
analyses should be maximised, i.e. the region should be well
imputed. Sij is 1 if the jth variant is causal for the ith trait and 0
otherwise (Supplementary Information). A hypothesis uniquely
identifies traits which share a causal variant, traits which have
distinct causal variants and traits which do not have a causal
variant. Except for the null hypothesis (H0) of no causal variant
for any trait, hypotheses such as Hm: all m traits share a causal
variant correspond to multiple configuration matrices, S (Fig. 1).
By considering the set of configurations to which a hypothesis
corresponds, the posterior odds of the hypothesis against the null
hypothesis can be computed. For example, let Sm denote the set
of configurations for hypothesis Hm and S0 denote the single
configuration for H0, then the posterior odds for the hypothesis










p S0ð Þ ð1Þ
where D represents the combined trait data, the first term in
the summation is a Bayes factor and the second term is a prior
odds2,8. To identify a candidate causal variant across the m traits,
i.e. to perform multi-trait fine-mapping, we locate the configura-
tion S* satisfying maxS2Sm P S Djð Þ ¼ P S* Dj
 
. If the summary
data for the genetic associations between traits are independent,
then the Bayes factor for each configuration S can be computed
by combining Wakefield’s approximate Bayes factors13 for each
trait in the configuration (‘Methods’). If the summary data
between traits are correlated because a subset of the participant
data was used in at least two of the GWAS analyses, then an
extension to Wakefield’s approximate Bayes factors, which jointly
models the trait associations, can be employed (‘Methods’). For a
given hypothesis H and set of corresponding configurations SH ,
the prior probability of configuration S, p(S), can either be equal
for all S 2 SH , or can be defined as a product of variant-level
priors (‘Methods’). Our variant-level prior extends that of
COLOC2 and MOLOC8 to a framework that is suitable for the
analysis of large numbers of traits. We adopt an approach which
requires the specification of a partition of the traits into clusters,
together with two interpretable parameters: p, the probability that
a variant is causal for one trait; and pc, the conditional probability
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that a variant is causal for a second trait given it is causal for one
trait (‘Methods’). As it will be helpful later, we refer to pc as the
conditional colocalization prior. COLOC2 requires specification
of three prior parameters {p1, p2, p12} and, while the scope of the
configuration priors in HyPrColoc is different for more than a
pair of traits, it is instructive to note that p≡ pi, for i 2 f1; 2g,
and pc  p12p12þp1
 
when m= 2. To help users of the COLOC2
software, our software allows users to specify the parameter p and
one of either (i) pc; or (ii) p12, from which pc is computed. For
simplicity and as a conservative measure, we assume a priori that
the genetic association probability p and the conditional
colocalization probability pc are equal for all traits. This approach
allows sensitivity analyses assessing robustness of posterior
inference to be routinely performed. However, it implicitly
assumes traits are a priori exchangeable, e.g. assumes p1= p2; this
is supported across a range of designs (case/control or
quantitative trait) but may lead to poorer performance in specific
datasets14.
Efficient computation of the posterior probability of full
colocalization (PPFC). For a pre-specified genomic region
comprising Q variants, the aim is to evaluate the PPFC, P(Hm|D),
that allm traits share a causal variant within that region, given the
summarized data D. According to Bayes’ rule, this is given by:
PPFC : P HmjDð Þ ¼
P
S2Sm PðDjSÞ ´ p Sð Þ
pðDÞ : ð2Þ
Brute-force computation of the denominator, p(D), requires
the exhaustive enumeration of (Q+ 1)m causal configurations,
which is computationally prohibitive for m > 4, e.g. MOLOC8.
HyPrColoc overcomes this challenge by approximating p(D) in a
way that is both computationally efficient, i.e. has fast computa-
tional time, and tightly bounds the approximation error.
As we show in the ‘Methods’, the PPFC can be approximated
as dPPFC ¼ PRPA; ð3Þ
where PR, PA > 0 are rapidly computable values that quantify
the probability that two criteria necessary for colocalization are
satisfied (Fig. 2). The first of these criteria is that all the traits
must share an association with one or more variants within the
region. PR, which we refer to as the regional association
probability, is the probability that this criterion is satisfied. By
itself, this criterion does not guarantee that there is a single causal
variant shared by all traits, because it could be the case that two or
more traits have distinct causal variants in strong LD with one
another. To safeguard against this, we have a second criterion that
ensures the shared associations between all traits are owing to a
single shared putative causal variant. PA is the probability that
this second criterion is satisfied. We refer to PA as the alignment
probability as it quantifies the probability of alignment at a single
causal variant between the shared associations. Both PR and PA
have linear computational cost in the number of traits m, making
a calculation of dPPFC possible when analysing vast numbers of
traits. If the first criterion is satisfied, but the second is not, this
may be because it is possible to partition the traits into clusters,
such that each cluster has a distinct causal variant. HyPrColoc
additionally seeks to identify these clusters.
Identification of clusters of colocalized traits. If dPPFC falls
below a threshold value, τ, we reject the hypothesis Hm that all
m traits colocalize to a shared causal variant. In practice, this
threshold is specified by defining separate thresholds, P*R and
P*A, for PR and PA, such that τ ¼ P*RP*A (‘Methods’). If Hm is
rejected, HyPrColoc seeks to determine if there are values ‘<m
such that H‘ cannot be rejected; i.e. if there exist subsets of the
Fig. 1 Colocalization hypotheses and causal configurations. Statistical colocalization hypotheses and examples of their associated SNP configurations that
allow for at most one causal variant for each of m traits in a region containing Q genetic variants. For clarity, the hypotheses and a single configuration
associated with each hypothesis are shown for m≥ 4 traits, but the column totals Bell (m+ 1) and (Q+ 1)m are correct for m≥ 2.
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traits such that all traits within the same subset colocalize to a
shared causal variant. Starting with a single cluster containing
all m traits, our branch and bound divisive clustering algorithm
(Supplementary Figs. S1a, b) iteratively partitions the traits into
larger numbers of clusters, stopping the process of partitioning





A. The process of partitioning a cluster
into two smaller clusters is performed using one of two criteria:
(i) regional (PR) or (ii) alignment (PA) selection (‘Methods’ and
Supplementary Note). For k ≤m traits in a cluster, the regional
selection criterion has O kQð Þ computational cost and is com-
puted from a collection of hypotheses that assume not all traits
in a cluster colocalize because one of the traits does not have a
causal variant in the region. The alignment selection criterion
has O kQ2ð Þ computational cost and is computed from
hypotheses that assume not all traits in a cluster colocalize
because one of the traits has a causal variant elsewhere in the
region (Supplementary Note). By default, the HyPrColoc soft-
ware uses the more computationally efficient regional selection
criterion to partition a cluster.
Model validation using simulations. We created simulated
datasets by resampling phased haplotypes from the European
samples in 1000 Genomes15 and for each dataset we randomly
selected one of the first 50 regions confirmed to be associated with
CHD16 (‘Methods’). For each simulation scenario, 1000 replicates
were performed.
Computational efficiency. The posterior probability of colocali-
zation, across m traits and in a region of Q variants, can be
accurately approximated by computing O mQ2ð Þ causal config-
urations. Figure 3 illustrates this for varying numbers of inde-
pendent studies and variants, demonstrating a close linear
relationship between computation time and the number of traits.
Consequently, HyPrColoc is able to assess 100 traits, in a region
of 1000 SNPs, in under 1 second compared to MOLOC which
takes approximately 1 hour to analyse five traits. For m ≤ 4, traits
the median absolute relative difference between the HyPrColoc
and MOLOC8 posterior probabilities was found to be ⪅ 0.5%
(Fig. 3).
Performance of HyPrColoc to detect multi-trait colocalization.
We used simulated datasets in which all traits colocalize to assess
the accuracy of HyPrColoc in detecting colocalization across
varying numbers of traits and study sample sizes. We simulated
independent datasets with sample sizes of 5,000, 10,000, and
20,000 individuals for up to 100 quantitative traits and for which
all traits share a single causal variant explaining either 0.5%, 1%
or 2% of trait variance. For each simulated dataset, we used
HyPrColoc to approximate the PPFC. The distribution of PPFC
across the simulated datasets was narrower in the analysis of two
traits relative to a larger number of traits, as the probability of
random misalignment of the lead variant between traits increases
as the number of traits increases (top Fig. 4). However, the esti-
mated PPFC is always close to 1 for 5, 10 and 20 traits illustrating
that the distribution of the estimate is stable across a broad
Fig. 2 Illustration of the HyPrColoc approximation.We illustrate the HyPrColoc approach with m= 2 traits. Statistical colocalization between traits which
do not share an association region, i.e. do not have shared genetic predictors, is not possible (no colocalization criteria satisfied). However, traits which do
(satisfying criterion 1) possess the possibility. HyPrColoc first assesses evidence supporting all m traits sharing an association region, which quickly
identifies utility in a colocalization framework. HyPrColoc then assesses whether any shared association region is due to colocalization between the traits
(criteria 1 and 2) or due to a region of strong LD between two distinct causal variants, one for each trait (criterion 1 only). Results from these two
calculations are combined to accurately approximate the PPFC.
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number of traits and sample sizes. For 100 traits there is a small
decrease in power due to the growth in the number of hypotheses
in which only a subset of the traits colocalize. This is expected
when sample size is fixed and the shared causal variant explains
only a small fraction of trait variation for each trait, as combined
evidence supporting hypotheses in which a subset of the traits
colocalize are eventually greater than evidence supporting full
colocalization.
When at least one trait did not have a causal variant in the
region the false detection rate was negligible. For example,
we generated 100 quantitative traits, each from a study with
sample size 10,000, in which 99 traits share a causal variant and
the remaining trait had either: (i) a distinct causal variant or (ii)
no causal variant in the region. In each scenario a causal variant
explained 1% of trait variation. The 1st, 5th (median) and 9th
deciles of the PPFC were (4 × 10−24, 1 × 10−17, 5 × 10−8) in
scenario (i) and (0.02, 0.05, 0.10) in scenario (ii). There is a
considerable difference between the results from each scenario,
but the PPFC is below the threshold for declaring colocalization
in both situations.
Fine mapping the causal variant with HyPrColoc. The pro-
portion which HyPrColoc correctly identified the true causal
variant increased as the number of colocalized traits included in
the analyses increased up to 2-fold, irrespective of sample size and
variance explained by the causal variant (middle Fig. 4), high-
lighting a major benefit of performing multi-trait fine-mapping. If
HyPrColoc identified a variant that was not the true causal var-
iant, we computed the LD between the true causal variant and the
identified variant. In cases where the identified variant was not
the causal variant, the variant was typically in very strong LD
(median r2 ≥ 0.99) with the true causal variant and for large
numbers of traits, i.e. m ≥ 20, with sample size 20,000, the two
variants were in perfect LD, i.e. r2= 1 (bottom Fig. 4).
Branch and bound divisive clustering algorithm. Here we assess
the performance of the branch and bound (BB) divisive clustering
algorithm to identify clusters of colocalized traits over a range of
scenarios, several specifications of the conditional colocalization
prior pc and using three classification criteria. The criteria were:
accuracy, which is an overall measure of the classification of traits
into clusters; true positive rate (TPR) and false positive rate
(FPR), see Methods for more details. We simulated 10 traits from
non-overlapping datasets under three scenarios: (i) a single
cluster of 10 colocalized traits; (ii) 2 clusters of 3 colocalized traits,
the remaining 4 traits do not have a causal variant (reflecting
hypothesis free colocalization searches) and (iii) 4 clusters of
colocalized traits, comprising 2 clusters of 3 traits and 2 clusters
of 2 traits. Scenarios (ii) and (iii) are designed to simultaneously
investigate potential false and true positive findings. Each cluster
of colocalized traits share a single causal variant and causal var-
iants between clusters are distinct, but can be in perfect LD, i.e.
r2= 1, with one another—we assess results when the single causal
variant assumption is violated later. To mirror real scenarios in
which data are taken from studies with different sample sizes, we
take the number of individuals in each study (Ni) as a random
draw from the set Ni∈ {1k, 5k, 10k, 15k, 20k}. For comparison,
we additionally present results when all studies have a large
sample size by also performing an analysis in which Ni= 15k for
all traits. In all scenarios, the causal variant for each trait
explained 1% of trait variance and the probability parameters
were set to P*R ¼ P*A ¼ 0:5 (‘Methods’). Following the approach of
Wallace14, we assess sensitivity to the choice of colocalization
prior pc, i.e. (1− γ). Across a wide range of simulated data,
Wallace14 demonstrated that setting p12= 5 × 10−6 in COLOC
(approximately pc= 0.05 in HyPrColoc) was generally a robust
choice. Starting from this value, we evaluated results with more
conservative choices of pc by performing three separate analyses
for each dataset using pc∈ {0.05, 0.02, 0.01}, equivalent to p12 ≈
{5 × 10−6, 2 × 10−6, 1 × 10−6} with p= 10−4 fixed14, in order to
Fig. 3 Comparison of HyPrColoc and MOLOC computation time and posterior probability of colocalization. (Left panel) Computation time (seconds) for
HyPrColoc (yellow) and MOLOC (blue) to assess full colocalization across M≤ 1000 traits in a region containing Q= 1000 SNPs. MOLOC was restricted
to M≤ 5 traits owing to the computational and memory burden of the MOLOC algorithm when M > 5. When M= 5, we summarise the computation time
of MOLOC from 10 datasets - as it took around 1 hour to analyse a single dataset, in all other scenarios performance was summarised from 1000 datasets.
Three reference lines are plotted: (i) Bell(M+ 1), which denotes the theoretical cost of exhaustively enumerating all hypotheses; (ii)M2, denoting quadratic
cost and; (ii)M1, denoting the linear complexity of the HyPrColoc algorithm. (Right panel) Distribution of the posterior probability of colocalization between
all traits, i.e. the posterior probability of full colocalization (PPFC), using HyPrColoc (yellow) and MOLOC (blue) across M∈ {2,3,4} traits. Error bars
denote the 1st and 9th deciles and a point denotes the median value. Despite differences in the prior set-up between the methods, the median absolute
relative difference between the two posterior probabilities was ≲ 0.005.
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identify a robust choice of pc. These values can result in sub-
stantial differences in the prior probability of colocalization as the
number of traits in a cluster increases (‘Methods’). For compar-
ison, we compare HyPrColoc against the alternative of per-
forming pairwise colocalization analyses using COLOC2, which
restricts clusters’ sizes to two traits only. Results are presented in
Figs. 5, 6 and Supplementary Fig. S2.
We observed that both HyPrColoc and pairwise COLOC
perform reasonably well across all three scenarios. The median
accuracy and TPR is generally ≥0.75, for all three choices of pc,
improving to around 1 when the sample size of each study is large
(Supplementary Fig. S2a, b; Supplementary Table S6)—indicating
that including studies with smaller sample sizes decreases the
TPR. Accuracy was more sensitive to the choice of pc when all
traits colocalized into a single cluster, i.e. scenario (i), relative to
scenarios (ii) and (iii) where we observed little sensitivity to pc
(Supplementary Fig. S2a). We noted increased variability in the
TPR when traits that do not have a causal variant were included
in analyses, i.e. scenario (ii), particularly using the more stringent
colocalization prior pc= 0.01 (Supplementary Fig. S2b). The FPR
was generally low across all scenarios and prior choices: the 1st
decile and median values were all zero. However, in scenario (iii),
when there are 4 clusters of traits and 4 causal variants in the
region, the 9th decile of the FPR increased for both methods, from
around zero in scenario (ii) up to 0.16, 0.1 and 0.08 when pc was
0.05, 0.02 and 0.01, respectively (Supplementary Fig. S2c). The
increase in FPR in scenario (iii) was a consequence of HyPrColoc
occasionally wrongly including an extra trait in one of the clusters
(Fig. 5b), and the pairwise approach overestimating the number
of clusters (Supplementary Fig. S1c). This was because the causal
variants from distinct clusters were in strong LD, i.e. r2 > 0.95, the
FPR of both methods reduced when excluding causal variants in
strong LD (Supplementary Fig. S3). Over all scenarios, HyPrCo-
loc regularly identified both the correct number of clusters of
colocalized traits in the data (Fig. 5a) as well as the correct
number of colocalized traits within each cluster (Fig. 5b). The
pairwise approach resulted in more variation in the number of
clusters identified (Supplementary Fig. S1c). HyPrColoc can
Fig. 4 Assessment of the HyPrColoc posterior probability. Simulation results for a sample size N∈ {5,000, 10,000, 20,000} and a causal variant
explaining {0.5%, 1%, 2%} of variation across m∈ {2, 5, 10, 20, 100} traits. Presented is the distribution of the HyPrColoc posterior probability of full
colocalization (PPFC) for variant-level priors only (top); the probability of correctly identifying the causal variant (middle) and; linkage disequilibrium
between an incorrectly identified causal variant and the true causal variant (bottom). Error bars denote the 1st and 9th deciles and a point denotes the
median value and performance was summarised from 1000 simulated datasets. Comparing performance across increasing study sample size and variance
explained by the causal variant, power to detect all colocalized traits is reduced when including studies with smaller sample sizes (top row), however,
including these studies can still boost the probability of correctly identifying the shared causal variant irrespective of variance explained (middle row).
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assign more than a pair of traits to a cluster, allowing information
about the location of any shared causal variant to be borrowed
across multiple traits, and therefore performed better at
identifying the shared causal variant (Supplementary Fig. S2d).
HyPrColoc significantly outperformed the pairwise approach
when summarising results from the clusters of colocalized traits
whose posterior probability satisfied PRPA > 0.7 (Fig. 6; Supple-
mentary Table S7). This procedure reflects common practice, as
colocalization results are generally only reported when the
posterior probability of colocalization is greater than a threshold
value, which we take here to be 0.7. Across all three scenarios,
clusters of colocalized traits identified by HyPrColoc had a
median accuracy and TPR of 1, with little sensitivity to the
different choices of colocalization prior pc. The FPR reduced also,
for example in scenario (iii) when pc= 0.01, the 1st, median and
9th deciles of the FPR were all zero. The FPR reduced for the
pairwise approach after thresholding, but the TPR reduced as
well. In pairwise approaches, a cluster of 3 or more colocalized
traits is identified if and only if all pairs of traits colocalize (ideally
at the same shared causal variant), the TPR of the pairwise
method reduced after thresholding as only some of the pairs of
traits passed the posterior threshold which increased the false
negative rate. This is a drawback of methods which do not
perform multi-trait colocalization. We repeated this simulation
procedure for 20 traits and the results were similar (Supplemen-
tary Fig. S3B), highlighting the scalability of HyPrColoc to
identify larger clusters of colocalized traits. Overall, across the
range of scenarios considered the selection algorithm performed
well in terms of sensitivity, specificity and accuracy. In
many situations there will not be a strong prior belief in a single
value for pc. Based on our results and previous investigations14,
we recommend users set pc= 0.02 and report results from
the clusters of colocalized traits which satisfy PRPA > 0.7. Setting
pc= 0.02 increased the number of datasets in which clusters
satisfying PRPA > 0.7 were identified (‘Methods’) while maintain-
ing a low FPR throughout. The HyPrColoc default pc= 0.02 is
equivalent to setting p12 ≈ 2 × 10−6 which, for a pair of traits, is
slightly more conservative than the recommended value of p12=
5 × 10−6 by Wallace14. For more than a pair of traits, however, it
can be much more conservative, e.g. setting pc= 0.05 (i.e. p12 ≈
5 × 10−6) returns a prior probability of colocalization across
10 traits that is around 2000 times larger than when setting pc=
0.02 (i.e. p12 ≈ 2 × 10−6).
In scenarios (i), (ii) and (iii), HyPrColoc identified the clusters
of colocalized traits on average 50, 30 and 25 times faster than the
pairwise COLOC approach, indicating some sensitivity in
computational performance to the type of colocalization structure
present in the data. These figures improved to 200, 100 and 75
times faster when analysing 20 traits. The computational gains of
HyPrColoc make it practical to perform multiple rounds of
colocalization analyses, each with different values of the prior pc
and the threshold parameters P*R; P
*
A, to assess any sensitivity in
the clusters of colocalized traits identified to changes in parameter
specifications. An example of this, taken from data generated
under scenario (iii), is presented in Fig. 7a. The resulting heatmap
highlights the presence of four clusters of colocalized traits in the
data and these clusters persist across most of the prior and
threshold parameter settings. We include this sensitivity analysis
in the HyPrColoc software and recommend its use.
We further tested the algorithm using a variety of thresholds
fP*R; P*Ag and two different prior frameworks (Supplementary
Figs. S9–S10). We also assessed results in the presence of
correlated traits and overlapping samples (Supplementary
Information). We analysed these data in three ways: (a) ignoring
all correlation, i.e. wrongly assuming non-overlapping partici-
pants between pairs of studies and ignoring known trait
Fig. 5 Number of clusters of colocalized traits and number of traits within a cluster. Results from the single causal variant simulation study (c.f.
Supplementary Fig. S2), presenting a the number of clusters of colocalized traits; and b the number of traits within each cluster identified by HyPrColoc.
Error bars denote the 1st and 9th deciles and a point denotes the median value.
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correlation when setting the configuration prior probabilities; (b)
adjusting for correlation between the summary data in the
computation of the likelihood only; and (c) adjusting for
correlation in the computation of the likelihood and accounting
for known trait correlation when setting the configuration prior
probabilities. Our findings suggest that analyses which account
for correlation in the computation of the likelihood should also
account for any known trait correlation in the configuration prior
probabilities: the posterior probability of colocalization between
the truly colocalized traits in scenario (b), which ignored known
correlation when setting the configuration prior, was significantly
smaller than in scenario (c) - leading to a single large cluster of
colocalized traits being split into smaller clusters (Supplementary
Fig. S11 and Supplementary Table S2). Our results indicated that
scenario (a), i.e. ignoring all correlation by treating studies as
independent and traits as a-priori exchangeable, even when there
Fig. 6 Performance of the BB clustering algorithm when excluding clusters of colocalized traits with lower posterior probability. In each of the three
scenarios presented, m= 10 traits with non-overlapping samples were generated, trait sample sizes were drawn randomly from the set N= {1,000, 5,000,
10,000, 15,000, 20,000} and variant-level causal configuration priors were used with three choices of the colocalization prior pc∈ {0.05, 0.02, 0.01}. In
scenario (i) there is one cluster of 10 colocalized traits; in scenario (ii) there are 2 clusters of colocalized traits, each comprising of 3 traits, the remaining 4
traits do not have causal variants and; in scenario (iii) there are 4 clusters of colocalized traits, 2 clusters of 3 traits and 2 clusters of 2 traits sharing a
causal variant. Traits within a cluster share a single causal variant and causal variants between clusters are distinct, however, a distinct variant can be in
perfect LD, i.e. r2= 1, with another distinct variant. In all scenarios, we present results that passed the posterior probability of colocalization PRPA≥ 0.7.
Presented are the classification measures: a accuracy; b true positive rate; and c the false positive rate. See ‘Methods’ for a description of how we define
these in the context of clusters of colocalized traits. In d we present the LD between the identified causal variant for each cluster of colocalized traits and
the true causal variant for each cluster. Error bars denote the 1st and 9th deciles and a point denotes the median value. The results highlight that on
increasing the posterior threshold from 0.5 (c.f. Supplementary Fig. S2) to 0.7, HyPrColoc’s ability to cluster multiple traits together demonstrably
improves accuracy and the true positive rate relative to pairwise analyses.
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is complete sample overlap (i.e. participants are the same in all
studies), gives reasonable results and in our assessment was
comparable to scenario (c) (Supplementary Fig. S10 and
Tables S2–S3). We discuss the theoretical reasons for this in
the Supplementary Information. We additionally provide an
example analysis protocol in our online vignette, which accom-
panies our software (https://github.com/cnfoley/hyprcoloc), offering
further guidance on the choice of prior configuration probabilities
and assessing any sensitivity of the clusters of colocalized traits
identified to the choice of prior parameters.
Violations of the single causal variant assumption. We assessed
the performance of HyPrColoc when two or more traits
have more than a single causal variant in the region. We simu-
lated data for 10 traits and allowed up to 5 traits to have addi-
tional distinct causal variants in the region, so that the sample
contains a mixture of traits which either satisfy or violate the
single causal variant assumption. The data are generated under
three scenarios, as previously, but now each cluster of colocalized
traits share a single causal variant and half of the traits in a cluster
have secondary distinct causal variants (‘Methods’). In terms of
marginal genetic associations, the additional variants were ran-
domly selected to explain either slightly less trait variance than
the shared causal variant (≈0.75%) or the same amount of trait
variance as the shared variant (≈1%).
The median accuracy and TPR of HyPrColoc reduced by as
much as 38% - in scenario (i) - and had greater variation
between the 1st and 9th deciles when the single causal variant
assumption was violated (Supplementary Figs. S4a,b); the
reduction in performance was less pronounced when all studies
had a large sample size. The FPR remained modest however, i.e.
the 1st decile and median FPR were zero. A slight increase in
the 9th decile of the FPR was noted when causal variants from
distinct clusters were in strong LD, i.e. r2 > 0.95, removing
these reduced the FPR to zero (Supplementary Fig. S5c). For
larger samples sizes, the 1st, median and 9th deciles of the FPR
were approximately zero for each choice of prior (Supplemen-
tary Fig. S4c). When considering only the clusters of traits
identified as colocalizing with PRPA > 0.7, HyPrColoc again
provided very reliable results across all three classification measures
(Supplementary Fig. S6a–c). Using the default settings {p= 10−4,
pc= 0.02}, the algorithm generally performed well: in scenario
(i) HyPrColoc regularly identified 8 of 10 traits as jointly
colocalized; in scenario (ii) 5 out of 6 traits and; in scenario
(iii) both clusters of colocalized traits, comprising 5 and 3 traits
respectively (Supplementary Fig. S4f) - highlighting HyPrColoc is
conservative when additional causal variants explain similar
amounts of trait variation as the shared causal variant. We provide
an illustration of HyPrColoc’s sensitivity analysis tool under
scenario (iii) (Fig. 7b) - correctly highlighting the presence of two
clusters of colocalized traits. After applying more stringent prior
and threshold values, one cluster reduced from 5 traits down to the
3 traits which have and share a single causal variant. This suggests
strong evidence of 3 traits and weak evidence of 5 traits in the
cluster. While the approach should be tailored to the problem at
hand, if the analysis flags considerable sensitivity to the specification
of the prior, we suggest: (a) reporting the clusters of colocalized
traits identified as colocalizing with PRPA > 0.7 using the con-
servative prior setting pc= 0.02; and (b) where computationally
practical, running pairwise analyses using a multi causal variant
method, e.g. eCAVIAR5 or ENLOC6, on the traits or clusters of
traits which are reported in (a) but are not identified as colocalizing
with PRPA > 0.7 using the more stringent prior pc= 0.01 - this may
help clarify if traits are being removed from clusters owing to the
presence of additional non-shared causal variants, e.g. scenario
(iii) (Fig. 7b), and should therefore be reported. We provide further
guidance on the reliability of the BB algorithm when secondary
causal variants are added to all traits in the region and when varying
LD between causal variants (Supplementary Information; Supple-
mentary Table S5).
We also compared results with those obtained using pairwise
COLOC and eCAVIAR5 (with a colocalization posterior prob-
ability, CLPP, cut-off of 1% and default prior choices), another
software package for colocalization which allows each trait to
have multiple causal variants but is limited to the analysis of pair
of traits only. We note that the SNP level CLPP measure of
eCAVIAR is computed in the presence of multiple causal variants
and is distinct from the SNP level probabilities, computed under a
single causal variant assumption, which comprise the posterior
probability measure returned by HyPrColoc and COLOC -
making comparisons between the methods challenging. We
compare the methods as they are used in practice, summarizing
HyPrColoc and COLOC using the posterior probability of the
Fig. 7 HyPrColoc’s sensitivity analysis. Heatmap visualizing changes in the clusters of colocalized traits identified by HyPrColoc when using different
choices of the colocalization prior pc= {0.05, 0.02, 0.01, 0.005} and algorithm thresholds PR ¼ PA ¼ f0:5;0:6;0:7g. Cells appear darker when trait pairs
cluster more often. Data were generated under scenario (iii) and when: a the single causal variant assumption is satisfied; or b the single causal variant
assumption is violated.
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hypothesis that a cluster or a pair of traits colocalize2,8,14 and
summarizing eCAVIAR using the SNP-level CLPP. Our choice of
CLPP cut-off of 1% was shown to have a low FPR across a range
of scenarios previously5. In our analyses we found that pairwise
eCAVIAR had increased accuracy relative to HyPrColoc and
pairwise COLOC, e.g. in scenario (i) median accuracy improved
by as much as 0.15 (when sample sizes varied) and 0.2 (when
sample sizes were large) (Supplementary Fig. S4a and Table S8).
Broadly, this was a result of the single causal variant methods
having a lower TPR (Supplementary Fig. S4a, b). However, by
borrowing information between multiple traits HyPrColoc out-
performed eCAVIAR when fine-mapping the shared causal
variant (Supplementary Fig. S4d)—despite not incorporating
LD information. After thresholding the posterior to PRPA > 0.7,
HyPrColoc again outperformed pairwise COLOC (Supplemen-
tary Fig. S6a–c).
Despite violations of the single causal variant assumption, our
analyses demonstrate that HyPrColoc can continue to identify
clusters of colocalized traits, returning conservative results
otherwise, with major computational advantages over competing
software: in the analysis of 10 traits and in a region containing
around 1000 SNPs, the single joint colocalization analysis of
HyPrColoc was computed approximately 100,000 times faster
than the 45 pairwise analyses of eCAVIAR. The HyPrColoc
algorithm can additionally be used to rapidly identify genomic
regions and clusters of traits to better prioritize the use of more
computationally expensive multi-causal variant colocalization
software for pairs of traits (Supplementary Information).
Map of genetic risk shared across CHD and related traits. We
used HyPrColoc to investigate genetic associations shared across
CHD17 and 14 related traits: 12 CHD risk factors18–22, a
comorbidity23 and a social factor24 (Supplementary Table S1 for
details). We performed colocalization analyses in pre-defined
disjoint LD blocks spanning the entire genome25. To highlight
that multi-trait colocalization analyses can aid discovery of new
disease-associated loci, we used the CARDIoGRAMplusC4D 2015
data for CHD17, which brought the total number of CHD-
associated regions to 58, and contrasted our findings with the
current total of ~160 CHD-associated regions26. For each region
in which CHD and at least one related trait colocalized, we
integrated whole blood gene expression27 quantitative trait loci
(eQTL) and protein expression28 quantitative trait loci (pQTL)
information into our analyses to prioritise candidate causal genes
(‘Methods’).
Multi-trait colocalization. Our genome-wide analysis identified
43 regions in which CHD colocalized with one or more related
traits (Fig. 8 and Tables 1–3). Twenty-three of the 43 colocali-
zations involved blood pressure, consistent with blood pressure
being an important risk factor for CHD29. Other traits coloca-
lizing with CHD across multiple genomic regions were choles-
terol measures (16 regions); adiposity measures (9 regions); type 2
diabetes (T2D; 4 regions) and; rheumatoid arthritis (2 regions).
Moreover, by colocalizing CHD and related traits, our analyses
suggest these traits share some biological pathways.
In thirty-eight of the 43 (88%) colocalized regions, the candidate
causal SNP proposed by HyPrColoc and/or its nearest gene, have
been previously identified16,17,26,30–35. Importantly, 20 of these were
reported after the CARDIoGRAMplusC4D study17. For example,
FGF5 was sub-genome-wide significant (P > 5 × 10−8) with CHD in
the 2015 data, but through colocalization with blood pressure, we
highlight it as a CHD locus and it is genome-wide significant in the
most recent CHD GWAS26. The remaining 18 regions were
reported previously, but one, APOA1-C3-A4-A5, was sub-genome-
wide significant in the CARDIoGRAMplusC4D study17 despite
having been reported previously35. However, we used HyPrColoc to
show that the association of major lipids colocalize with a CHD
signal, highlighting this as a CHD locus in these data (Table 1 and
Supplementary Fig. S13). The locus has subsequently been
replicated26,31 and we show below that the signal also colocalizes
with circulating apolipoprotein A-V protein levels (Table 1). This
demonstrates that joint colocalization analyses of diseases and
related traits can improve power to detect new associations (an
approach which is advocated outside of colocalization studies36).
Our results also illustrate that multi-trait colocalization analyses can
provide further insights into well-known risk-loci of complex
disease. For example, at the well-studied SH2B3-ATXN2 region26,35,
HyPrColoc detected two cholesterol measures (LDL, HDL), two
blood pressure measures (SBP, DBP) and rheumatoid arthritis (RA)
colocalizing with CHD at the previously reported CHD-associated
SNP26 rs7137828 (PPFC= 0.909 of which 76.8% is explained by the
variant rs7137828; Fig. 8). In addition, we implicated a candidate
SNP and locus in a further 5 CHD regions not previously associated
with CHD risk (Table 3). In one of the 5 regions, CYP26A1, CHD
colocalized with tri-glycerides (TG) and HyPrColoc identified a
single variant that explained over 75% of the posterior probability of
colocalization, supporting this SNP as a candidate shared CHD/TG
variant.
For each of the 43 regions that shared genetic associations
across CHD and related traits, we further integrated whole blood
gene27 and protein28 expression into the colocalization analyses.
We tested cis eQTL for 1828 genes and cis pQTL from the 854
published proteins across the 43 loci for colocalization with CHD
and the related traits. Of the 43 listed variants (Tables 1–3), 27
were associated with expression of at least one gene (P < 5 × 10−8)
and a total of 125 such genes were identified. HyPrColoc refined
this, identifying six regions colocalizing with eQTL for one
expressed gene and one region, the FHL3 locus, colocalizing with
expression of three genes (SF3A3, UTP11L, RNU6-510P)
(Table 2). The GUCY1A3 locus has previously been associated
with BP37 and with CHD16. Here we show that these associations
are likely to be due to the same variant, rs72689147 (PPFC=
0.93), with the G allele increasing DBP and risk of CHD. We
furthermore show that the association colocalizes with expression
of GUCY1A1 in whole blood, with the G allele reducing
GUCY1A1 expression (PPFC= 0.77; Table 1). The GUCY1A1
gene is ubiquitously expressed in heart tissues, including in the
coronary and aortic arteries38. In the mouse, higher expression of
GUCY1A1 has been correlated with less atherosclerosis in the
aorta39. GUCY1A1 is a likely candidate gene in this locus40,
illustrating the utility of HyPrColoc to help prioritise candidate
causal genes. The CTRB2-BCAR1 locus was not known at the
time of the release of the 2015 CARDIoGRAMplusC4D data,
however we find the association at this locus is shared with T2D
(PPFC= 0.83) and that BCAR1 expression colocalized with the
CHD association (PPFC= 0.86). Other studies have implicated
the locus in CHD34 and suggested BCAR1 as the causal gene in
carotid intimal thickening41,42. We note that two CHD loci also
colocalize with circulating plasma proteins, APOA1-C3-A4-A5,
with apolipoprotein A-V and the APOE locus with apolipoprotein
E (Table 1).
Of the 38 known CHD loci that colocalized with a related trait,
8 are reported to have a single causal variant26, of these we
identified the same CHD-associated variant (or one in LD with
either r2 > 0.8 or |D′|> 0.8)15 at seven loci (SORT1, PHACTR1,
ZC3HC1, CDKN2B-AS1, KCNE2, CDH13, APOE). Despite the
possible presence of multiple causal associations at other loci,
HyPrColoc was still able to pick out single shared associations
across traits: a result supported by our simulation study when
additional distinct causal variants explain less or similar trait
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Fig. 8 Genome-wide multi-trait colocalization analysis of CHD and fourteen related traits. a Summary of the number of regions across the genome in
which CHD colocalizes with at least one related trait. Results are aggregated by trait family, e.g. major lipids, and by each individual trait (see
Supplementary Table S1 for a list of trait abbreviations). b Stacked association plots of CHD with high-density lipoprotein (HDL), low-density lipoprotein
(LDL), systolic blood pressure (SBP), diastolic blood pressure (DBP) and rheumatoid arthritis (RA). HyPrColoc implicated both the SH2B3-ATXN2 locus and
risk variant rs713782, both of which have been previously reported as associated with CHD risk26. However, HyPrColoc extended this result by identifying
that the risk loci and variant are shared with 5 conventional CHD risk factors11. SNPs in stronger LD with the putative causal SNP rs713782 appear darker in
the plot. c HyPrColoc identified rs713782 as a candidate causal variant explaining the shared association signal between CHD and the 5 related traits. The
posterior probability of colocalization between the traits was 0.909 and rs713782 explained over 76% of this, i.e. the posterior probability of rs713782
being the shared causal variant is 0.909 × 0.76= 0.69. The next candidate variant explained <20%.
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variation than that explained by a shared causal variant between
colocalized traits (Supplementary Information). In our analyses,
we set pc= 0.02, i.e. γ= 0.98, and report only the clusters of traits
whose posterior probability of colocalization was greater than 0.7.
We assessed sensitivity to the choice of colocalization prior,
repeating analyses with pc= 0.01, and found no appreciable
difference in the clusters identified (results not reported).
Discussion
We have developed and applied a deterministic Bayesian colo-
calization algorithm, HyPrColoc, for multi-trait statistical colo-
calization analyses. HyPrColoc is based on the same underlying
statistical model as COLOC2, but enables colocalization analyses
to be performed across massive numbers of traits, owing to the
insight that the posterior probability of colocalization at a single
causal variant can be accurately approximated by enumerating
only a small number of putative causal configurations. HyPrColoc
avoids repeated rounds of pairwise colocalization analyses which
can inflate the false negative rate and have reduced performance
in identifying a shared causal variant. The HyPrColoc algorithm
was validated using simulations and used to assess genetic risk
shared across CHD and related traits. Using CHD data from
201517, in which 46 regions were genome-wide significant (P <
5 × 10−8), our multi-trait colocalization analysis identified 43
regions in which CHD colocalized with ≥1 related trait. With this
approach, we were able to identify CHD loci that were not known
at the time of the data release (2015), demonstrating the benefit of
synthesising data on related traits to uncover potential new
disease-associated loci8,36. A further five regions, we postulate,
may be identified as CHD loci in the future. Others have con-
sidered pleiotropic effects of CHD loci previously43, but our
formal colocalization analyses are more robust, e.g. in the ABO
region we show colocalization of T2D and DBP in addition to the
previously reported pleiotropic effect with LDL. We integrated
eQTL and pQTL data to prioritise candidate genes at some loci,
e.g. GUCY1A1, BCAR1 and APOE.
The HyPrColoc algorithm identifies regions of the genome where
there is evidence of a shared causal variant (by dissecting the
genome into distinct regions) and also allows for a targeted analysis
of a specific genomic locus of primary interest, e.g. when aiming to
identify the perturbation of a biological pathway through the
influence of a particular gene. Moreover, these region-specific
analyses can highlight candidate causal genes, which will help
improve biological understanding and may indicate potential drug
targets to inform medicines development44.
We have described HyPrColoc under the assumption of at
most one causal variant per trait. Future work is required to
extend this methodology and algorithm to multiple-causal var-
iants. We note that the reliability of results under the single causal
variant assumption only break down when secondary causal
variants explain as much trait variation as the shared variant
(Supplementary Information). An example of which is the
expression of SH2B3, where multiple causal variants for the
expression of this gene masks colocalization with the CHD signal,
we discuss an approach to building colocalization analyses which
might help support the single causal variant assumption (Sup-
plementary Information). We note that misspecification of LD
between causal variants has a major impact on correct detection
of multiple causal variants in a region45, making a single causal
variant assessment the most reliable when accurate study-level
LD information is not available. To overcome challenges when
specifying the prior probability of a causal configuration, we have
suggested two different parsimonious configuration priors
(‘Methods’). The computational advantages of HyPrColoc make it
practical to assess sensitivity of results to the specification of prior
and threshold parameters as part of regular use. The HyPrColoc
software includes a tool to do this, visualizing any changes in the
clusters of colocalized traits identified as parameters are varied.
Nevertheless, other priors may be more appropriate for particular
applications.
In summary, we have developed a computationally efficient
method that can perform multi-trait colocalization on a large
scale. As the size and scale of available data on genetic associa-
tions with traits increase, computationally scalable methods such
as HyPrColoc will be increasingly valuable in prioritizing causal
genes and revealing causal pathways.
Methods
SNP association models. Let Yi denote one of i= 1,2,…,m, traits assessed in a
maximum of m studies, i.e. two or more traits can be measured in the same study,
and Gij denote the genotype of the jth genetic variant. It is assumed that the
outcome model for Yi is given by
E Yi Gij
h i ¼ h1i αij þ βijGij ; ð4Þ
where αij is the intercept term and hi is a function linking the ith outcome to the
genotype Gij, for all j= 1,2,…,Q genetic variants in the genomic region. The
function hi is typically taken as the identity function for continuous traits and the
logit function for binary traits. The aim of colocalization analyses is to identify
genomic loci where there exists an Gij that is causally associated with at least two of
the m traits. For each of the m traits and Q genetic variants, we assume that GWAS
summary statistics β̂ij and var β̂ij
 
are available. We use these data to perform
colocalization analyses in genomic loci.
Colocalization posterior probability. Using binary vectors to indicate whether a
variant putatively causally influences a trait, we can define causal configurations (S)
that can be grouped into sets (SH ) which belong to a single data generating
hypothesis (H). We use the notation H i;j;¼ð Þ to denote a set of hypotheses in which
a collection of i traits share a causal variant, a separate collection of j traits share a
distinct causal variant, and so on (Fig. 1). For, example, H 2;1ð Þ denotes the set of
hypotheses in which each hypothesis specifies uniquely 2 traits that share a causal
variant, a single trait has a distinct causal variant and all remaining m−3 traits do
not have a causal variant in the region. Assuming at most one causal variant for
each trait these data generating hypotheses can be combined to generate a
hypothesis space (Ω). The posterior probability of hypothesis H, given the com-
bined data D from all m studies, can therefore be computed using (Supplementary
Table 3 New CHD loci sharing colocalized associations with related traits.







6 FHL5 CHD, SBP rs9486719 (Intron) FHL5 – 0.844 (0.1542) – –
10 CYP26A1 CHD, TG rs2068888 (Downstream) CYP26A1 – 0.8454 (0.7669) – –
16 ANKRD11 CHD, WC rs11643561 (Intron) ANKRD11 – 0.7827 (0.0795) – –
19 RSPH6A CHD, SBP rs8108474 (Intron) RSPH6A – 0.7802 (0.1435) – –
20 PREX1 CHD,
SBP, DBP
rs79044887 (Intron) PREX1 – 0.7237 (0.132) – –
HyPrColoc identified five regions—not yet reported as CHD genetic risk loci—with colocalized associations across CHD and one or more related trait. See Table 1 for a full description of table items.
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Information),










where p(S)/p(S0) is the prior-odds of configuration S 2 SH compared with the null-
configuration S0, i.e. no genetic association with any trait. See ref. 2 for a derivation with
m= 2 traits. BF(S) is a Bayes factor which is the likelihood of the data being generated
under S 2 SH relative to the likelihood of the data being generated S0.
We describe the space of multi-trait colocalization models using a set of
mutually exclusive hypotheses and causal configurations as this approach
extends the methodology and language used previously2,8. We note, however,
that each causal configuration is equivalent to a model which, for each trait,
details the location of the causal variant in the region. Hence, the problem of
identifying a hypothesis and causal configuration with the greatest support given
the data D, is equivalent to identifying the joint trait-variant model with greatest
support2,13.
Computing Bayes factors: independent studies. If the trait associations are
calculated using independent studies (i.e. no overlapping samples in the GWAS
datasets), the Bayes factors can be computed using Wakefield’s Approximate Bayes














where zij, vij and wij are the Z-statistic, standard error and the prior standard
deviation for β̂ij , respectively. Following
2, for continuous variables wij is set to 0.15
while for binary traits it is set to 0.2. As an example, the ABF for the hypothesis that







Calculating Bayes factors: non-independent studies. If the trait associations are
not calculated using independent studies i.e. there are overlapping samples, the
Bayes factor for each causal configuration can be computed using a Joint ABF
(JABF) (Supplementary Information). The JABF for causal configuration S is given
by,


















where β̂ is the vector of regression coefficients for all m traits, Σβ̂ is an m ×m
variance-covariance matrix of the regression coefficients (i.e. V ρ̂V , where V2 is a
diagonal matrix of variances for the regression coefficients, e.g. with ith diagonal
element v2i , and ρ̂ is the observed correlation matrix for the regression coefficients)
and Σβ is the prior variance-covariance matrix (i.e. WρW, where W
2 is a diagonal
matrix of prior variance, e.g. with ith diagonal element w2i, and ρ is the prior
correlation matrix between traits). The correlation matrix (ρ̂) is computed using
the tetrachoric correlation method46 and we discuss our approach to setting ρ in
the Supplementary Information.
Configuration prior probabilities. We consider two different strategies for
determining the priors for different hypotheses: variant-level priors and uniform
priors.
Variant-level prior probabilities. The prior probability space for a single genetic
variant can be fully partitioned into the prior probability that the genetic variant is
not associated with any of the m traits, p0, the prior probability that the genetic
variant is associated with only the first trait, p1,…, the prior probability that the
SNP is associated with a subset of k traits {j1,j2,…,jk}, pj1 j2 ¼ jk , …, the prior











pj1 j2 ¼ jk
 !
¼ 1: ð9Þ
The space therefore requires the specification of 2m prior parameters which,
even for modest values of m, is computationally impractical. Following2,8 we set
that the prior probability to not vary by genetic variant, nor by the specific
collection of colocalized traits of a given size, but by the number of colocalized
traits, i.e. a SNP associated with a total of k traits has a prior probability that
depends on the number k but not the specific collection of traits. To allow for the
assessment of large numbers of traits we propose variant-level priors where the
prior probability that a genetic variant is associated with k traits is given by,
p12¼ k ¼ p
Yk
i¼2
1 γi1 ; k ¼ 2; ¼m; ð10Þ
where p is the probability of the genetic variant being associated with one trait
and γ is a parameter which controls the probability that a genetic variant is
associated with an additional trait. Notably, 1− γ is the probability of a variant
being causal for a second trait given it is causal for one trait, i.e. it is the conditional
colocalization prior pc,
pc ¼ 1 γ;











1 γi1 ; k ¼ 2; ¼ ;m; ð11Þ
for configurations S 2 SHk , where k traits share a causal variant and the
remaining m− k traits do not have a casual variant, and
p Sð Þ
p S0ð Þ






1 γi1 ; ð12Þ
for configurations S 2 SHðm1;1Þ , where m− 1 traits share a causal variant and the
remaining trait has a distinct causal variant. This prior set-up allows evidence to
grow in favour of k traits colocalizing conditional on evidence supporting k− 1 traits
colocalizing (Supplementary Information). For example, if the first k traits are
believed to share a causal variant a-priori, then the prior probability that the (k+ 1)th
is also colocalized, conditional on the other k traits, increases as the number of
colocalized traits k grows. The marginal prior probability of k traits colocalizing is
always very small, however, which controls the false positive rate (Fig. 6 and
Supplementary Figs. S2–6; Supplementary Tables S2–3). Conditional growth limits
the loss of power when assessing colocalization across a large number of traits. A loss
in power necessarily occurs when analysing large numbers of colocalized traits, due to
the rapid growth in the number of hypotheses in which a subset of traits can
colocalize relative to all traits colocalizing. Evidence supporting these ‘subset’
hypotheses will eventually overwhelm evidence in favour of the maximum number of
truly colocalized traits for a fixed sample size (top row Fig. 4). Based on our
simulation results (Fig. 6 and Supplementary Figs. S2–6) and previous
investigations14, we recommend users set pc= 0.02, i.e. γ= 0.98, and report results
from the clusters of colocalized traits which satisfy PRPA > 0.7. Setting pc= 0.02
increased the number of datasets in which clusters satisfying PRPA > 0.7 were
identified (c.f. simulation study) while maintaining a low FPR throughout. Using the
same posterior threshold of 0.7 and setting pc= 0.05 returned reasonable results.
However, we do not recommend users set pc= 0.05 due to the slight increase in the
9th decile of the FPR in scenario (iii) (Fig. 6c). If two or more traits in a cluster are
known to be related, this information would ideally be included in analyses and we
outline an extension to our prior setup which allows for non-exchangeability of traits
to be included (Supplementary Information).
Conditionally uniform prior probabilities. An alternative prior strategy is to
assume uniform priors for each configuration within a hypothesis47. This strategy
benefits from: (i) not setting variant-level information and (ii) implicitly
accounting for large differences in the causal configuration space between
hypotheses, which limits the loss in power of the PPFC for very large m. These





¼ 1=jSH j; ð13Þ
where SHk
  ¼ Q and
SHðm1;1Þ
  ¼ Q Q 1ð Þ : m ¼ 2;




Through simulations, we identified the conditionally uniform prior as less
conservative than variant-level priors, having an increased false detection rate of
colocalization. (Supplementary Information; Supplementary Figs. S10, 11). This could
lead to an increased false positive detection rate in practice.
HyPrColoc posterior approximation. To compute the posterior probability of full
colocalization across a large number of traits we propose the HyPrColoc posterior
approximation. Let P(Hm|D), Pscv, P(m−1,1) and Pall denote: (i) the posterior
probability of full colocalization; (ii) the sum of the posterior probabilities in which
no traits have a causal variant, a subset of m− 1 traits share a causal variant
(the remaining trait does not have a causal variant) and all m traits colocalize (Pscv);
(iii) the sum of posterior probabilities in which a subset of m − 1 traits share a
causal variant and the remaining trait has a distinct causal variant (P(m−1,1))
and; (iv) the sum of all posterior probabilities of at most one causal variant per
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trait (Pall). That is,
Pscv ¼ P H0jDð Þ þ PðHm1jDÞ þ P HmjDð Þ and Pðm1;1Þ ¼ PðHðm1;1ÞjDÞ: ð15Þ
The HyPrColoc posterior is computed in two steps. Step 1 computes the









≥P HmjDð Þ: ð17Þ
Note that PR is computed using (m+ 1)Q causal configurations and PA is
computed using an additional mQ(Q− 1) causal configurations. Hence,
computation of PR and PA has O mQ2ð Þ computational cost. We let
Pcall ¼ Pall  Pscv  P m1;1ð Þ, then it follows that the posterior probability of all
traits sharing a single causal variant is given by













PðHm jDÞ PðHmjDÞ þ Pðm1;1Þ
 














¼ PRPA þO δ2A þ δRδA
 
; δR; δA ! 0;
ð18Þ
where δR= 1−PR, δA= 1−PA and
Pcall
Pðm1;1Þ
¼ O δR þ δAð Þ;
(Supplementary Information). By definition, PðHmjDÞ ! 1 , PR ! 1 and
PA ! 1. Hence together the regional and alignment probabilities when multiplied
form a statistic that is sufficient to accurately assess evidence of the full
colocalization hypothesis. The objects PR and PA can be defined for various
collections of hypotheses that partition Pall. However, the major insight is that the
hypotheses contained in PR and PA are computed with minimal computation
burden, i.e. computed using ≤mQ2 causal configurations, amongst all alternatives,
making the HyPrColoc approximation tractable for very large numbers of traits m.
Our software allows for the assessment of the HyPrColoc approximation by
increasing the number of hypotheses used to approximate PR, e.g. we can compute
P0R ¼
PðHmjDÞ
P H0jDð Þ þ P Hm2jDð Þ þ P Hm1jDð Þ þ PðHmjDÞ
; ð19Þ
which is computed from O m2Qð Þ causal configurations and assess the relative
difference between PR and P0R. We show that P
0
R ¼ PR 1þ δRð Þ (Supplementary
Information) and through simulations that there very close correspondence
between P0R and PR (Supplementary Table S4).
Branch and Bound divisive clustering algorithm. To identify complex patterns of
colocalization amongst all traits, we propose a branch and bound (BB) divisive
clustering algorithm that utilizes the HyPrColoc approximation to identify a cluster
of traits with the greatest evidence of colocalization at each iteration (Supple-
mentary Fig. S1a and Supplementary Information). Starting with all of the traits in
a single cluster, the algorithm explores evidence supporting any of 2m branches - a
branch represents a hypothesis whereby m− 1 traits share a causal variant and
either the remaining trait does not have a causal variant or has a causal variant
elsewhere in the region - against the full colocalization hypothesis. These branches
represent the hypotheses used in the computation of the regional and alignment
probabilities PR and PA. There are two bounds: (i) the minimum probability
required to accept evidence that all m traits are regionally associated P*R and (ii) the
minimum probability required to accept that the causal variant for all m traits
aligns at a single variant P*A . The BB algorithm accepts evidence supporting all m




A, after which the algorithm
returns the HyPrColoc estimate of PPFC and stops. If either PR < P
*
R or PA < P
*
A
there is insufficient evidence supporting all traits sharing a causal variant and the
BB algorithm moves to the branch with maximum evidence supporting m− 1
traits sharing a causal variant. At this point the traits are partitioned into two
clusters: one containing m− 1 traits deemed most likely to share a causal variant
and a second cluster containing the remaining trait. We repeat this process of
branch selection and partitioning on the cluster of m− 1 traits until we identify





A, or (B) there is one trait left in the cluster. In scenario A, the
HyPrColoc posterior probability that all k traits colocalize is presented and the
remaining m–k traits are assessed for evidence of colocalization using the branch
selection and partitioning scheme. In scenario B, the trait is deemed not colocalize
with any other trait in the sample and the BB selection algorithm is repeated using
m− 1 traits. The entire process is repeated until all clusters of colocalized traits,
whereby each cluster of traits colocalize at a distinct causal variant, have been
identified, all other traits are deemed not to share a causal variant with any
other trait.
Simulation study. To create genomic loci with realistic patterns of LD, for each
simulation scenario we simulated 1000 datasets and for each dataset we resampled
phased haplotypes from the European samples in 1000 Genomes15 and randomly
chose one of the first 50 regions confirmed to be associated with CHD16. After
removing variants with low MAF, i.e. MAF < 0.05, the number of SNPs analysed in
these regions ranged from 228, in the APOE region, to a maximum of 1918 SNPs
in the PDGFD region. The mean number of SNPs was 881.6. Unless stated
otherwise, for traits that have a causal variant in the region, the variant explains 1%
of trait variance. To go some way to mirroring real analyses, each trait was assumed
to be measured in studies with different sample sizes, i.e. the sample size for the i-th
study (Ni) was randomly chosen from the set Ni∈ {1,000, 5,000, 10,000, 15,000,
20,000}. Variant-level priors were chosen for the simulation study: we set p= 10−4 as
in refs. 2,14 and, to assess sensitivity of results to the choice of conditional colocali-
zation prior pc, we ran each simulation three times for each of pc∈ {0.05, 0.02, 0.01}.
Note that pc= 1− γ, so this is equivalent to γ∈ {0.95, 0.98, 0.99}. For a pair of traits,
colocalization between the traits is 5 times more likely a-priori when setting pc= 0.05
relative to pc= 0.01. In the analysis of ten traits, however, colocalization between all
ten traits is around 1 million times more likely a-priori when setting pc= 0.05 relative
to pc= 0.01. The prior probability of colocalization is still very small ~10−11 when
setting pc= 0.05, however. Hence, the different values of pc we have chosen can result
in substantial differences in the prior probability of colocalization.
Violations of the single causal variant assumption. These data were generated
under three scenarios: (i) a single cluster of 10 colocalized traits, each trait shares a
single causal variant and 5 traits have secondary distinct causal variants; (ii) a single
cluster of 6 colocalized traits, each of the 6 traits share a single causal variant and 3
traits have secondary distinct causal variants, the remaining 4 traits do not have
causal variants and; (iii) 2 clusters of colocalized traits, cluster 1 comprises 6 traits
sharing a single causal variant with 3 of 6 traits having secondary distinct causal
variants, cluster 2 comprises 4 traits sharing a single causal variant with 2 of 4 traits
having secondary distinct causal variants. To maximize the number of traits with
additional causal variants in a cluster (up to the maximum of 5), in scenarios (ii)
and (iii) the total number of clusters of colocalized traits were reduced relative to
the single causal variant assessment.
Measuring the accuracy, true positive and false positive rates of HyPrColoc
Accuracy ¼ TP þ TN
TP þ TN þ FP þ FN ;
True positive rate TPRð Þ ¼ TP
TP þ FN ;
False positive rateðFPRÞ ¼ FP
FP þ TN
where TP and TN denote the true positive count and true negative count, and
FP and FN denote the false positive count and false negative count. Hence,
accuracy is the proportion of traits that are correctly identified as colocalizing or
not colocalizing. To compare HyPrColoc with pairwise methods, we compute the
TP, FP, TN and FN rates by aggregating information across all pairs of traits in the
sample. A TP is measured when a pair of observations are correctly deemed to
colocalize, a FP is measured when a pair of traits are incorrectly identified as
colocalizing, a FN is recorded when a pair of traits are wrongly deemed not to colocalize
and a TN is recorded when a pair of traits are correctly identified as not colocalizing.
When thresholding the posterior probability of colocalization, the TP, FP, TN
and FN rates are computed after excluding traits which do not to colocalize with
any other trait such thatPAPR > 0.7. In the simulation study which allowed each
trait a maximum of one causal variant in the region and with respect to scenarios
(i), (ii) and (iii), when setting pc= 0.05 HyPrColoc identified clusters of colocalized
traits with PRPA > 0.7 in approximately 70%, 93% and 99% of simulated datasets,
when pc= 0.02 in approximately 65%, 91% and 98% datasets, reducing to around
60%, 86% and 97% of datasets when pc= 0.01. Pairwise COLOC identified pairs of
colocalized traits with PRPA > 0.7 in over 96% of simulated datasets, across all three
scenarios and specifications of pc. In the simulation study which allowed a
maximum of two causal variants per trait, these figures reduced: when setting pc=
0.05 HyPrColoc identified clusters of colocalized traits with PRPA > 0.7 in
approximately 65%, 80% and 93% of simulated datasets, when pc= 0.02 in ~60%,
72% and 92% datasets, reducing to around 55%, 65% and 85% of datasets when
pc= 0.01. Pairwise COLOC identified pairs of colocalized traits with PRPA > 0.7 in
over 94% of simulated datasets, across all three scenarios and specifications of pc
Application to CHD and cardiovascular risk factors. The GWAS results used in
the assessment of colocalization of CHD with related traits were taken from large-
scale analyses of CHD17, blood pressure (http://www.nealelab.is/uk-biobank),
adiposity measures (http://www.nealelab.is/uk-biobank), glycaemic traits18, renal
function19, type II diabetes20, lipid measurements21, smoking22, rheumatoid
arthritis23 and educational attainment24 (Table S1). All datasets had either been
imputed to 1000 Genomes15 prior to GWAS analyses or were imputed up to 1000
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Genomes from the summary results using DIST48 (INFO > 0.8). We performed
colocalization analyses in two steps. In step one, we assessed colocalization of CHD
with the 14 risk-factors in pre-specified LD blocks from across the genome25. We
used a conservative variant-level prior structure with p= 1 × 10−4 and γ= 0.98, i.e.
1 in 500,000 variants are expected to be causal for two traits, and set strong bounds
for the regional and alignment probabilities, i.e. P*R ¼ P*A ¼ 0:8 so that the algo-
rithm identified a cluster of colocalized traits only if PRPA > 0.64. The full results
from this analysis are available at https://jrs95.shinyapps.io/hyprcoloc_chd.
To prioritise candidate causal genes in regions where CHD and at least one
related trait colocalized, we re-ran the colocalization analysis and included
whole blood cis eQTL27 (31,684 samples) and cis pQTL28 (3301 samples) data in
addition to the primary traits in a second step, using the same LD blocks as
before. A colocalization analysis was performed for every transcript with data
within each region. cis eQTL were defined 1MB upstream and downstream of
the centre of the gene probe (1828 genes were analysed across the 43 regions).
cis pQTL were defined 5MB upstream and downstream of the transcript start
site (854 proteins were analysed across the 43 regions). We integrated gene
expression information taken from whole blood tissue as: (i) the eQTLGen
dataset27 has a large sample size relative to other publicly available gene
expression data resources and; (ii) the pQTL data were also measured in whole
blood tissues, so there was consistency in the tissue analysed.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The genome-wide association summary data that support the findings of this study are
available from: CARDIoGRAMplusC4D (http://www.cardiogramplusc4d.org) for
coronary heart disease; MAGIC (www.magicinvestigators.org) for glycaemic traits;
GLGC (www.lipidgenetics.org) for lipid measures; TAG (https://www.med.unc.edu/pgc/
download-results/tag/) for smoking; SSAGC (www.thessgac.org) for years in education;
DIAGRAM (https://www.diagram-consortium.org) for type 2 diabetes; CKDGen (http://
ckdgen.imbi.uni-freiburg.de/) for renal function measure eGFR; Okada et al. (http://
plaza.umin.ac.jp/~yokada/datasource/software.htm) for rheumatoid arthritis; and the
first release of the Neale Lab’s GWAS analysis of UK-Biobank (http://www.nealelab.is/
uk-biobank) for the adiposity measures and blood pressure traits. The summary data on
gene expression and protein expression in whole blood are available from eQTLGen
(http://www.eqtlgen.org/cis-eqtls.html) and Sun et al. (https://www.phpc.cam.ac.uk/ceu/
proteins/), respectively. The LD information was computed using the phased haplotypes
from the 1000 Genomes study (http://www.internationalgenome.org/). Full results from
the genome-wide colocalization analysis of CHD and 14 related traits using HyPrColoc
are available at https://jrs95.shinyapps.io/hyprcoloc_chd.
Code availability
We developed an R package for performing the HyPrColoc49 analyses (https://github.
com/cnfoley/hyprcoloc). Please visit the HyPrColoc Zenodo page (https://doi.org/
10.5281/zenodo.4293559) for information on how to cite the software. The regional
association plots (as seen in Fig. 8) were created using gassocplot (https://github.com/
jrs95/gassocplot) and LD information from 1000 Genomes15. We compared the
performance of HyPrColoc with the publicly available software packages: COLOC
(Version: 3.2-1; https://cran.r-project.org/web/packages/coloc/); eCAVIAR (Version:
2.0.0; https://github.com/fhormoz/caviar); and MOLOC (Version: 0.1.0; https://github.
com/clagiamba/moloc).
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